Cargando…

Treatment of Chronic Hepatitis C in a Patient Affected by Systemic Sclerosis

The currently recommended treatment for patients infected with hepatitis C virus (HCV) is pegilated interferon α (IFN α) plus ribavirin. Despite the numerous benefits of this therapy, there is an increasing concern regarding his tolerance. Among the most common side effects, interferon may trigger t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poggi, Guido, Villani, Laura, Sottotetti, Federico, Tagliaferri, Barbara, Montagna, Benedetta, Amatu, Alessio, Bernardo, Giovanni
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786055/ https://www.ncbi.nlm.nih.gov/pubmed/19997512 http://dx.doi.org/10.1155/2009/475390

Ejemplares similares

Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma
por: Poggi, Guido, et al.
Publicado: (2009)

Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
por: Tagliaferri, Barbara, et al.
Publicado: (2020)

Palbociclib in metastatic breast cancer: current evidence and real-life data
por: Serra, Francesco, et al.
Publicado: (2019)

A huge pancreatic mass
por: Poggi, Guido, et al.
Publicado: (2016)

Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience
por: Palumbo, Raffaella, et al.
Publicado: (2019)

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
por: Palumbo, Raffaella, et al.
Publicado: (2015)

Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study
por: Quaquarini, Erica, et al.
Publicado: (2022)

Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR(+)/HER2(−) breast cancer treated with CDK4/6 inhibitors and endocrine therapy
por: Tagliaferri, Barbara, et al.
Publicado: (2023)

Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study
por: Palumbo, Raffaella, et al.
Publicado: (2021)

The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors
por: Sottotetti, Federico, et al.
Publicado: (2022)

Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review
por: Schiepatti, Annalisa, et al.
Publicado: (2022)

Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients
por: Yuan, Man, et al.
Publicado: (2020)

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
por: Amatu, Alessio, et al.
Publicado: (2016)

Acute Hepatitis C After Penile Stem Cell Injection
por: Zaveri, Sahil, et al.
Publicado: (2022)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
por: Degasperi, Elisabetta, et al.
Publicado: (2014)

Chronic Hepatitis C
por: Jang, Jae Young, et al.
Publicado: (2011)

Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases
por: Franzè, Maria Stella, et al.
Publicado: (2022)

Tackling the clinical complexity of breast cancer
por: Lenti, Marco Vincenzo, et al.
Publicado: (2022)

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study
por: Söderholm, Jonas, et al.
Publicado: (2019)

Association between celiac disease and chronic hepatitis C
por: Casella, Giovanni, et al.
Publicado: (2016)

Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report
por: Covini, Giovanni, et al.
Publicado: (2018)

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2022)

Rosuvastatin and chronic hepatitis C
por: Yoshida, Eric M.
Publicado: (2011)

Chronic Hepatitis C with Cyanosis
por: Alawainati, Mahmood, et al.
Publicado: (2019)

The effect of iron depletion on chronic hepatitis C virus infection
por: Franchini, Massimo, et al.
Publicado: (2008)

DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
por: Burza, Maria Antonella, et al.
Publicado: (2015)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
por: Ahn, Young-Hwan, et al.
Publicado: (2019)

Visfatin serum concentration and hepatic mRNA expression in chronic hepatitis C
por: Kukla, Michał, et al.
Publicado: (2019)

Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2023)

Two-Dimensional Shear Wave Elastography versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C
por: Villani, Rosanna, et al.
Publicado: (2020)

Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit
por: Colli, Agostino, et al.
Publicado: (2016)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Genetic variants of IFIH1 and DHX58 affect the chronicity of hepatitis C in the Chinese Han population
por: Huang, Peng, et al.
Publicado: (2023)

Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis
por: Mollica, Ludovica, et al.
Publicado: (2021)

Occult hepatitis C infection identified in injection drug users with direct antiviral agents therapy and spontaneous resolution of hepatitis C virus infection
por: Silva, Eliane, et al.
Publicado: (2023)

New treatments for chronic hepatitis C
por: Jang, Jae Young, et al.
Publicado: (2010)

Chronic hepatitis C: future treatment
por: Wendt, Astrid, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b1p33aet7b4hvn5mh5t2eg0op4